ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Center Studies Prevention For Endometrial Cancer

February 25, 2005

In Brief: Krakoff moves To Scotland; Salmon Wins Waldenstrom Award; ONS endorses Reform

November 5, 1993

In Brief: Breakthrough Prize Awarded to 11 Scientists

March 8, 2013

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976

NCI Bypass Budget Justifies An Extra $900 Million In FY1992; Cancer costs Estimate At $80B A Year

January 11, 1991

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012